$ cat ./records/gates-foundation-announces-2-5-billion-womens-health-investment-i-2025.txt
Gates Foundation Announces $2.5 Billion Women's Health Investment Including 8-Year IUD Rollout
[RECORD.TXT] · cat --full
The Gates Foundation announced a $2.5 billion commitment through 2030 to advance women's health across five priority areas: obstetric care, maternal nutrition, gynaecological health, contraceptive options, and STI treatment. A centrepiece was the large-scale rollout of Avibela — an 8-year levonorgestrel-releasing intrauterine system with 99 percent efficacy — beginning with Kenya and Nigeria in 2025. The commitment also funded development of a contraceptive patch and new treatments for conditions affecting women disproportionately in low-income settings.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Breakthrough Energy Ventures Invests in Savor — Butter Made Directly from Carbon
Next →
Gates Foundation Commits $1.4 Billion for Climate-Resilient Agriculture in Africa and Asia
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.